Long-term blood sugar control may not affect macrovascular atherosclerosis in type 1 diabetes patients: Study
Finland: A recent study published in Acta Diabetologica revealed no association between long-term blood glucose control and carotid intima-media thickness (CIMT) in patients with type 1 diabetes implying that in these patients, the development of early signs of macrovascular atherosclerosis is not strongly affected by the glycemic control.
Carotid intima-media thickness is a surrogate marker of atherosclerosis that predicts cardiovascular events, particularly stroke and myocardial infarction. It can be measured using ultrasound of the two innermost layers of the tunica intima, carotid artery wall, and tunica media. Ultrasound of the CIMT provides a reproducible, easy non-invasive tool to evaluate the risk of cardiovascular disease (CVD).
Type 1 diabetes (T1D) is known to increase the risk of cardiovascular disease and T1D patients are at a sixfold increased risk of stroke versus non-diabetic individuals. The researchers note that these patients with T1D have increased CIMT compared to healthy controls. Recent studies have shown that CIMT is a potential indicator of cerebral small vessel disease in patients with T1D, irrespective of blood glucose control. Jussi Inkeri, University of Helsinki, Helsinki, Finland, and colleagues aimed to explore the relationship between CIMT and the current glycemic control, as well as the long-term glycemic control over the preceding ten years, in a well-characterized cohort of Finnish individuals with type 1 diabetes.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.